Evaluation of Cancer Dependence and Druggability of PRP4 Kinase Using Cellular, Biochemical, and Structural Approaches-Reference-Cited by-同舟云学术

Evaluation of Cancer Dependence and Druggability of PRP4 Kinase Using Cellular, Biochemical, and Structural Approaches

Published:2013-10 Issue:42 Volume:288 Page:30125-30138
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Gao Qiang,Mechin Ingrid,Kothari Nayantara,Guo Zhuyan,Deng Gejing,Haas Kimberly,McManus Jessica,Hoffmann Dietmar,Wang Anlai,Wiederschain Dmitri,Rocnik Jennifer,Czechtizky Werngard,Chen Xin,McLean Larry,Arlt Heike,Harper David,Liu Feng,Majid Tahir,Patel Vinod,Lengauer Christoph,Garcia-Echeverria Carlos,Zhang Bailin,Cheng Hong,Dorsch Marion,Huang Shih-Min A.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference40 articles.

1. prp4 from Schizosaccharomyces pombe, a mutant deficient in pre-mRNA splicing isolated using genes containing artificial introns;Rosenberg;Mol. Gen. Genet,1991

2. Cloning of human PRP4 reveals interaction with Clk1;Kojima;J. Biol. Chem,2001

3. Mammalian PRP4 kinase copurifies and interacts with components of both the U5 snRNP and the N-CoR deacetylase complexes;Dellaire;Mol. Cell. Biol,2002

4. PRP4 is a spindle assembly checkpoint protein required for MPS1, MAD1, and MAD2 localization to the kinetochores;Montembault;J. Cell Biol,2007

5. Interaction of PRP4 with Kruppel-like factor 13 regulates CCL5 transcription;Huang;J. Immunol,2007

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CMGC Kinases in Health and Cancer;Cancers;2023-07-28

2. GATA6 coordinates cross-talk between BMP10 and oxidative stress axis in pulmonary arterial hypertension;Scientific Reports;2023-04-22

3. Structure Activity Relationship Studies around DB18, a Potent and Selective Inhibitor of CLK Kinases;Molecules;2022-09-20

4. Discovery of novel benzothiophene derivatives as potent and narrow spectrum inhibitors of DYRK1A and DYRK1B;Bioorganic & Medicinal Chemistry Letters;2022-07

5. Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation;Nature Communications;2021-11-16